by McDermott + Bull | Aug 26, 2022 | Investor Insights, Ken Dropiewski, Video
McDermott + Bull Partner Ken Dropiewski interviews CRG Director Sabir Rassiwalla in his series, Investor Insights in Life Sciences + MedTech. In the conversations below, Ken and Sabir discuss MedTech’s continuously changing landscape, what makes CRG different...
by McDermott + Bull | Aug 22, 2022 | Brandon Biegenzahn, Brandon Biegenzahn Placement Announcement, Financial Services, Financial Services Placement Announcement, Placement Announcement, Rachel Crisi
McDermott + Bull has successfully placed Mahlon “Mac” McCaleb as Chief Financial Officer (CFO) at Seattle Credit Union. Mac will play an integral role in shaping the future of the Credit Union and will be a visible strategic and operational leader, driving Seattle...
by McDermott + Bull | Aug 19, 2022 | Jake Vander Zanden, Let's Chat
In my recent conversations with senior leaders, I’ve noticed there is a lot of talk about digital transformation, and many CEOs are struggling to figure out where they fit within this. The CEO’s responsibility is to serve as the heartbeat of an organization, driving...
by McDermott + Bull | Aug 19, 2022 | Industrial, Manufacturing, + Distribution, Interim Industrial, Manufacturing, + Distribution Placement Announcement, Interim Leaders, Interim Placement Announcement, James Hickey, James Hickey Placement Announcement, Tamra Solis
McDermott + Bull Interim Leaders Senior Managing Director James Hickey and Vice President of Talent Acquisition Tamra Solis have successfully placed a project Chief Financial Officer (CFO) for a California-based building products company. The company is in the...
by McDermott + Bull | Aug 15, 2022 | Healthcare + Life Sciences, Healthcare + Life Sciences Placement Announcement, Jake Vander Zanden, Jake Vander Zanden Placement Announcement, Placement Announcement
McDermott + Bull has successfully placed Kevin Belteau as Vice President (VP) of Clinical Affairs at enVVeno Medical. Kevin will develop, implement, and execute the company’s U.S. clinical trial strategy, ensuring the highest possible performance of clinical affairs...
